Archive for March, 2008

Palliative care: careless use of language undermines our identity.

Saturday, March 29th, 2008

Palliative care: careless use of language undermines our identity. Hanks G.

Therapeutic potential (2).

Saturday, March 29th, 2008

Therapeutic potential (2). Silverman G, Linnik M. UCSD Rheumatic Diseases Core Center, UCSD School of Medicine, La Jolla, California, USA.

Therapeutic potential (1).

Saturday, March 29th, 2008

Therapeutic potential (1). Zack DJ, Isenberg D. Amgen, Thousand Oaks, California, USA.

Antibodies and other biomarkers - pathological consequences (2).

Saturday, March 29th, 2008

Antibodies and other biomarkers - pathological consequences (2). Ehrenstein M, Alves J. Centre for Rheumatology Research, Windeyer Institute of Medical Science, University College London, London, UK.

Pathogenic factors for the development of lupus nephritis.

Saturday, March 29th, 2008

Pathogenic factors for the development of lupus nephritis. Mason Lj, Berden J. Department of Medicine, Centre for Rheumatology Research, University College London, London, UK.

Signalling defects and cellular interactions (2).

Saturday, March 29th, 2008

Signalling defects and cellular interactions (2). Datta S, Mauri C. Division of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ilinois, USA.

Autoantibodies and other biomarkers - pathological consequences (1).

Saturday, March 29th, 2008

Autoantibodies and other biomarkers - pathological consequences (1). Giles I, Putterman C. University College London, London, UK.

Cellular interactions and signalling defects in lupus (1).

Saturday, March 29th, 2008

Cellular interactions and signalling defects in lupus (1). Zouali M, Mageed R. Inserm U606 and University of Paris Diderot-Paris, Paris, France.

Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases.

Saturday, March 29th, 2008

Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases. Rahman A, Stollar B. Division of Medicine, Centre for Rheumatology, University College London, London, UK.

Introduction to a systemic lupus erythematosus - biomarkers meeting held at University College Londo

Saturday, March 29th, 2008

Introduction to a systemic lupus erythematosus - biomarkers meeting held at University College London on 23rd and 24th February 2007. Isenberg D, Ehrenstein M, Rahman A. Department of Medicine, Centre for Rheumatology, University College London, London, UK.

Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren’s syndrome.

Saturday, March 29th, 2008

Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren\'s syndrome. Sánchez-Cano D, Callejas-Rubio J, Lara-Jiménez M, López-Trascasa M, Circadi M, Ortego-Centeno N. Hospital Universitario San Cecilio, Unidad de Enfermedades Autoinmunes Sistémicas, Granada, Spain.

Systemic lupus erythematosus in the Fars Province of Iran.

Saturday, March 29th, 2008

Systemic lupus erythematosus in the Fars Province of Iran. Abstract Clinical features of systemic lupus erythematosus (SLE) have been described from different geographical regions in the world. However, data from many Middle East countries, including Iran, are scarce. This study aims to demonstrate the demographic, clinical, ...

Hypothyroidism determines the clinical and immunological manifestations of Arabs with lupus.

Saturday, March 29th, 2008

Hypothyroidism determines the clinical and immunological manifestations of Arabs with lupus. Abstract Data on thyroid disease in Arabs with lupus is scarce. We conducted a cross-sectional and retrospective case-control study to report the prevalence of thyroid diseases in 110 Arabs with lupus who attended our Rheumatology ...

Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a pa

Saturday, March 29th, 2008

Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus. Abstract Amegakaryocytic thrombocytopenia is an extremely rare disorder in systemic lupus erythematosus, and its mechanism and treatment are still largely unknown. We describe a 42-year-old woman with systemic lupus erythematosus ...

Severe digital ischemia-a presenting symptom of malignancy-associated antiphospholipid syndrome.

Saturday, March 29th, 2008

Severe digital ischemia-a presenting symptom of malignancy-associated antiphospholipid syndrome. The association of the antiphospholipid syndrome with malignancy has been extensively reported. Raynaud\'s phenomenon has also been reported to be associated with various malignancies. In this report, we describe two patients who presented with severe digital ischemia ...

Sulpha allergy in lupus patients: a clinical perspective.

Saturday, March 29th, 2008

Sulpha allergy in lupus patients: a clinical perspective. Abstract Systemic lupus erythematosus is a chronic, relapsing autoimmune disease that can affect multiple organ systems. An increased prevalence of drug allergy has been reported in lupus patients compared with the general population. Using a cohort of 417 ...

E/E’ ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction

Saturday, March 29th, 2008

E/E\' ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus. Abstract To investigate whether the ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (E\') (E/E\' ratio) can detect left ventricular ...

Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesi

Saturday, March 29th, 2008

Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome? Abstract A premature atherosclerosis has been presumed in patients with antiphospholipid syndrome. The potential role of antiphospholipid antibodies in the development of atheroma is rather controversial. In this study, we ...

Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort

Saturday, March 29th, 2008

Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort. Abstract The objective of this study was to determine risk factors predicting seizures and damage caused by seizures in a multi-ethnic systemic lupus erythematosus cohort (PROFILE) that includes systemic lupus erythematosus patients ...

High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patient

Saturday, March 29th, 2008

High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease. Autoantibodies against dense fine speckles 70 (DFS70) are found in 10% of healthy individuals, but only in a tiny population of patients with autoimmune rheumatic disease. The antibody may thus be a ...

Lupus: improving long-term prognosis.

Saturday, March 29th, 2008

Lupus: improving long-term prognosis. AbstractOver recent decades short- and medium-term survival has greatly improved in patients affected with systemic lupus erythematosus, but long-term prognosis still remains poor mainly due to complications of the disease and/or its treatment. To improve long-term prognosis in systemic lupus erythematosus, we ...

Viruses and lupus: the viral hypothesis.

Saturday, March 29th, 2008

Viruses and lupus: the viral hypothesis. Ramos-Casals M. Laboratory of Autoimmune Diseases \"Josep Font\" Hospital Clínic, Barcelona, Spain.

Pituitary tumor apoplexy: a review.

Saturday, March 29th, 2008

Pituitary tumor apoplexy: a review. Laws ER. Department of Neurosurgery, Stanford University Medical Center, Advanced Medicine Center, 875 Blake Wilbur Dr Room CC-2330, MC 5821, Stanford, California. erlaws@stanford.edu.

Measurement of central venous pressure from a peripheral intravenous catheter following cardiopulmon

Saturday, March 29th, 2008

Measurement of central venous pressure from a peripheral intravenous catheter following cardiopulmonary bypass in infants and children with congenital heart disease. The current study evaluates the feasibility and accuracy of measuring central venous pressure from a peripheral intravenous catheter following cardiopulmonary bypass in infants and children. ...

Experience in the management of eighty-two newborns with congenital diaphragmatic hernia treated wit

Saturday, March 29th, 2008

Experience in the management of eighty-two newborns with congenital diaphragmatic hernia treated with high-frequency oscillatory ventilation and delayed surgery without the use of extracorporeal membrane oxygenation. The aim of this study is to analyze neonatal outcome of isolated congenital diaphragmatic hernia and to identify prenatal and ...

page 70 page 140 page 210 page 280 page 350 page 420 page 490 page 550 page 590 page 690 page 790